Cat#: | RP-258A |
Product Name: | Recombinant MERS-CoV (NCoV / Novel coronavirus) Spike Protein fragment (aa 383-502, Fc Tag) |
Synonym: | S |
Description: | A DNA sequence encoding the spike protein fragment (Human betacoronavirus 2c EMC/2012)( AFS88936.1)(Cys383-Lys502) was fused with Fc region of mouse IgG at the C-terminus. |
Source: | Baculovirus-Insect Cells |
Predicted N Terminal: | Cys 383 |
Molecular Characterization: | The recombinant spike protein fragment (Human betacoronavirus 2c EMC/2012) comprises 354 amino acids and has a predicted molecular mass of 39.7 kDa. It migrates as an approximately 44 kDa band in SDS-PAGE under reducing conditions. |
Purity: | Greater than 85 % as determined by SDS-PAGE |
Endotoxin: | < 1.0 EU per ug of the protein as determined by the LAL method |
Bioactivity: | Please contact us for detailed information |
Formulation: | Lyophilized from sterile 100mM Glycine, 10mM Nacl, pH 7.0. |
Stability: | Recombinant Proteins are stable for up to 1 year from date of receipt at -70℃ |
Reconstitution: | Please see related COA for specific instructions. |
Storage: | Avoid repeated freeze-thaw cycles. In lyophilized state for 1 year (4-8℃); Upon reconstitution under sterile conditions for 2 weeks (4-8℃) or 3 months (-20℃ to -70℃). |